Kingstron Bio (Changshu) Co., Ltd., founded in 2012, is an innovative medical device enterprise focusing on the field of structural heart disease. The company is mainly engaged in the R&D and production of prosthetic biological heart valves, transcatheter heart valves, valve annuloplasty rings, biological patches and other products, committed to providing safer and more effective treatment solutions for patients with cardiovascular diseases.
Headquartered in Changshu High-tech Industrial Park, Jiangsu Province, the company has built an integrated platform covering research, development and production, with strong independent innovation capabilities and industrialization capacity. Kingstron Bio owns a number of core patented technologies, including the Micro-Ex anti-calcification treatment technology and dry valve preservation technology, reaching the internationally advanced level in improving the durability of biological heart valves.
